Analgesics in Latvia - New Market Research Report

Research by the Centre for Disease Prevention and Control, which was published in 2015, reveals that 25% of the population had used medicines to treat headaches, while 26% did so to fight other kinds of pain, during the last week when asked. The growing habit of using medicines even for minor pain, improving consumer purchasing power with higher disposable incomes, and switching to more expensive products due to delivery problems with cheaper alternatives from Ukraine all resulted in an increase in value sales of analgesics in 2015.

Competitive Landscape

Nycomed Pharma AS was the leading player in analgesics with a 32% value share in 2015 in Latvia. The driver of its success is the Ibumetin brand and its 400mg variant, which was the leading OTC medicine during the whole review period. The rest of analgesics is very fragmented. GL Pharma with its brand Thrombo ASS reached second position in 2015, as Ukrainian producer Stirolbiofarm, which is represented in Latvia by several analgesics brands, saw its value share decline due to problems with supplies.

Full Report Details at
- http://www.fastmr.com/prod/1082076_analgesics_latvia.aspx?afid=301

Industry Prospects

Analgesics will continue to demonstrate stable growth over the forecast period due to the increasing trend towards using medicines even for minor pain and the increasing number among the elderly population who will need pain relief medicines or aspirin to sustain their cardio systems on a regular basis.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Latvia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Latvia, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Latvia market research report includes:

* Analysis of key supply-side and demand trends
* Detailed segmentation of international and local products
* Historic volumes and values, company and brand market shares
* Five year forecasts of market trends and market growth
* Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

* What is the market size of Analgesics in Latvia?
* What are the major brands in Latvia?
* Are combination products with acetaminophen still popular?

Reasons to Get this Report

* Gain competitive intelligence about market leaders
* Track key industry trends, opportunities and threats

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Analgesics in South Korea
- Analgesics in Tunisia
- Analgesics in the United Arab Emirates
- Analgesics in Mexico
- Analgesics in Algeria